OTCMKTS:THERF - Theratechnologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$5.1050 -0.09 (-1.73 %)
(As of 03/18/2019 03:32 PM ET)
Previous Close$5.20
Today's Range$5.1530 - $5.26
52-Week Range$5.0905 - $11.25
Volume54,784 shs
Average Volume50,061 shs
Market Capitalization$392.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.56
Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada.

Receive THERF News and Ratings via Email

Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:THERF
Previous SymbolNASDAQ:THER
CUSIPN/A
CIKN/A
Phone514-336-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.18 million
Book Value$0.44 per share

Profitability

Net Income$-4,640,000.00

Miscellaneous

EmployeesN/A
Market Cap$392.58 million
Next Earnings Date4/4/2019 (Estimated)
OptionableNot Optionable

Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions

What is Theratechnologies' stock symbol?

Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (OTCMKTS:THERF) posted its quarterly earnings data on Thursday, February, 21st. The company reported ($0.02) earnings per share for the quarter. The company had revenue of $13.85 million for the quarter. Theratechnologies had a negative return on equity of 7.73% and a negative net margin of 10.42%. View Theratechnologies' Earnings History.

When is Theratechnologies' next earnings date?

Theratechnologies is scheduled to release their next quarterly earnings announcement on Thursday, April 4th 2019. View Earnings Estimates for Theratechnologies.

What is the consensus analysts' recommendation for Theratechnologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Theratechnologies.

Has Theratechnologies been receiving favorable news coverage?

News coverage about THERF stock has trended somewhat positive this week, InfoTrie reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Theratechnologies earned a media sentiment score of 1.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future.

Who are some of Theratechnologies' key competitors?

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Theratechnologies (TH), Allena Pharmaceuticals (ALNA), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), Obseva (OBSV), GTX (GTXI), Sorrento Therapeutics (SRNE), Aurora Cannabis (ACBFF), Shopify (SHOP) and KemPharm (KMPH).

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the folowing people:
  • Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
  • Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)

How do I buy shares of Theratechnologies?

Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Theratechnologies' stock price today?

One share of THERF stock can currently be purchased for approximately $5.1050.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of $392.58 million and generates $45.18 million in revenue each year.

What is Theratechnologies' official website?

The official website for Theratechnologies is http://www.theratech.com.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected]


MarketBeat Community Rating for Theratechnologies (OTCMKTS THERF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  65 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe THERF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THERF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel